Rasmussen's syndrome and new-onset narcolepsy, cataplexy, and epilepsy in an adult

Epilepsy and Behavior

Volumn 4, Issue 6, 2003, Pages 788-792

  Lagrange, Andre H ^a   Blaivas, M ^b   Gomez Hassan, D ^b   Malow, B A ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Autoimmune disorder; Encephalitis; Epilepsy; Narcolepsy; Rasmussen's syndrome; Seizures; Sleep disorder; Temporal lobe

Indexed keywords

ANTIMALARIAL AGENT; CARBAMAZEPINE; ETIRACETAM; GABAPENTIN; HLA DQB1 ANTIGEN; IMIPRAMINE; LAMOTRIGINE; METHYLPHENIDATE; OREXIN; OXCARBAZEPINE; PHENYTOIN; SERTRALINE;

ADULT; ANAMNESIS; ARTICLE; AUTOIMMUNE DISEASE; BRAIN REGION; CASE REPORT; CATAPLEXY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COMPLEX PARTIAL SEIZURE; DISEASE COURSE; EPILEPSY; FRONTAL LOBE; HAPLOTYPE; HISTOPATHOLOGY; HLA SYSTEM; HUMAN; INSULA; MALE; NARCOLEPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANOIA; POLYSOMNOGRAPHY; POSITRON EMISSION TOMOGRAPHY; RASMUSSEN SYNDROME; SCREENING TEST; SEIZURE; SLEEP; SOMNOLENCE; TEMPORAL LOBE;

EID: 0346787768     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2003.08.030     Document Type: Article

References (12)

1. Mantegazza R, Bernasconi P, Baggi F, et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 2002;131:179-85.
2. Yang R, Puranam RS, Butler LS, et al. Autoimmunity to munc-18 in Rasmussen's encephalitis. Neuron 2000;28:375-83.
3. Rasmussen T, Olszewski J, Lloyd-Smith D. Focal seizures due to chronic localized encephalitis. Neurology 1958;8:435-45.
4. Bien CG, Widman G, Urbach H, et al. The natural history of Rasmussen's encephalitis. Brain 2002;125(Pt 8):1751-9.
5. McLachlan RS, Girvin JP, Blume WT, Reichman H. Rasmussen's chronic encephalitis in adults. Arch Neurol 1993;50:269-74.
6. Hart YM, Andermann F, Fish DR, et al. Chronic encephalitis and epilepsy in adults and adolescents: a variant of Rasmussen's syndrome. Neurology 1997;48:418-24.
7. Nishino S, Okura M, Mignot E. Narcolepsy: genetic predisposition and neuropharmacological mechanisms (Review article). Sleep Med Rev 2000;4:57-99.
8. Barcellos LF, Oksenberg JR, Begovich AB, et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 2003;72:710-6.
9. Younger DS, Pedley TA, Thorpy MJ. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology 1991;41:447-8.
10. Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 2003;53:154-66.
11. Malik S, Boeve BF, Krahn LE, Silber MH. Narcolepsy associated with other central nervous system disorders. Neurology 2001;57:539-41.
12. Pablos JL, del Rincon E, Francisco F, Mateo I. Narcolepsy in systemic lupus erythematosus. J Rheumatol 1993;20:375-6.